Research.Patient.info

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM
This early-stage study is testing a new treatment called TEG001. It's for adults with certain blood cancers like acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS), or multiple myeloma (MM) that have come back or are high-risk. The main goal is to see if TEG001 is safe for people to use.
Netherlands